This study evaluated IFN-γ and the IFN-γ–induced chemokines, CXCL9, CXCL10 and CXCL11, in active, untreated AOSD patients, and compared their levels with those in RA patients and HCs. This evidence concerns the gene IFNG and rheumatoid arthritis.